Tests a remote exercise program for people with inflammatory bowel disease
Tests a remote adapted exercise program in adults with Crohn's disease or ulcerative colitis.
Key facts
- Who runs it
- Raincy Montfermeil Hospital Group
- Where
- Montfermeil and Nantes, FranceSee the 2 sites
- Trial code
- Registry title
- Pilot Study Assessing the Feasibility and Impact of a Remote Adapted Physical Activity Program on Quality of Life in Patients With Inflammatory Bowel Disease (IBD)
- Status
- Recruiting
- People taking part
- 72 people, planned
- Started
- 15 Sept 2025
- Planned end
- 31 Mar 2026
- Type of study
- Interventional
- Treatments tested
- adapted physical activity
- Record updated
- 24 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who have had Crohn's disease or ulcerative colitis (IBD) for at least 6 months. They must be willing to do a 12-week physical activity program at home, online.
- Age
- 18 years and older
- Sex
- All
- Disease stage
- Inflammatory bowel disease (IBD) diagnosed at least 6 months ago
Main reasons for not taking part
- A medical reason not to do physical activity
- Already very physically active (above the set limits of the IPAQ questionnaire)
- A psychological disorder that could get in the way of taking part
- No device or internet connection to join from home
- Pregnant or breastfeeding women
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Adults aged 18 years and older
- Diagnosis of Inflammatory Bowel Disease (IBD) established for at least 6 months
- Patient is motivated to participate in the Adapted Physical Activity (APA) program
- Medical certificate confirming fitness to engage in remote physical activity
- Access to a digital device with internet connectivity enabling use of the MOOV+ application at home
- Written informed consent freely given after appropriate information
- Affiliation with, or beneficiary of, a national health insurance system
Who cannot take part
- Presence of psychological disorders that may interfere with study participation
- Patients under 18 years of age
- Medical contraindication to physical activity
- High levels of physical activity as defined by the International Physical Activity Questionnaire (IPAQ):; Total >1500 MET-min/week of vigorous activity on at least 3 days, OR; Total physical activity >3000 MET-min/week, regardless of distribution
- Lack of access to a device or internet connection enabling remote participation
- Pregnant or breastfeeding women
- Patients under legal guardianship or curatorship
- Patients under legal protection
Where in France
- Ghi Le Raincy-MontfermeilMontfermeil, FranceContact: Stephane NAHON, ProfessorTaking people
- CHU NantesNantes, FranceContact: Catherine LE BERRE, DoctorNot yet recruiting
About the trial
What the trial wants to find out
Inflammatory Bowel Disease (IBD) is a chronic relapsing condition that affects the gastrointestinal tract and is increasingly diagnosed in adolescents and young adults. Although anti-TNFα therapies are effective in reducing disease activity and improving quality of life, they are frequently associated with side effects such as fatigue, weight gain, and joint pain, which may be mitigated by regular physical activity.
Read full original descriptionShow less
Emerging evidence suggests that light to moderate physical activity may help reduce systemic and intestinal inflammation and improve IBD-related outcomes. However, access to structured physical activity programs remains limited, and personal or professional constraints may hinder participation.
This pilot study aims to assess the feasibility and impact of a remotely delivered Adapted Physical Activity (APA) program on the quality of life of patients with Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis. This study evaluates the effects of a 12-weeks remote APA intervention on quality of life as the primary outcome.
Secondary objectives include assessing changes in anxiety and depression, fatigue levels, IBD activity, and smoking behavior. The findings from this study may inform the development of scalable, non-pharmacological strategies to support symptom management and well-being in individuals with IBD.
The group in the trial
- Pre- and post-intervention comparison following participation in the Adapted Physical Activity (APA)Treatment being tested
There is no comparator group at this stage of the research. Patient data will be compared before and after participation in the Adapted Physical Activity (APA) program.
Treatment: adapted physical activity
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pilot Feasibility and Impact Study of a Remote Adapted Physical Activity Program on the Quality of Life of Patients With Inflammatory Bowel Disease (IBD)
- Plain-language title
- Tests a remote exercise program for people with inflammatory bowel diseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 24 September 2025